More and more women are becoming aware of the problems with transvaginal mesh.
A recent survey showed that more and more women who might be candidates for transvaginal mesh implant surgeries are finding out about the mesh through the number of lawsuits around the country. Each day, more and more women are stepping forward to tell their story about these products that have caused so much pain and suffering. A Tucson personal injury lawyer can guide patients through the process to help them ensure that their rights are protected.
Women who have had the transvaginal mesh implants have suffered from a variety of side effects. Some have had extreme pain, bleeding, and are at higher risk of infection.
For years, surgical mesh had been used to treat hernias, but in the 1990s, surgeons began using the mesh to correct pelvic organ prolapse, a condition that can sometimes present itself in women for a variety of reasons, including childbirth.
The mesh did not go through the rigorous testing process for pelvic application because it had already been used in the human body for hernia surgery. However, in the different biological environment of the pelvic region, the mesh performed far differently.
A transvaginal mesh lawyer can help if you have been the victim of these products. Their lack of testing and their poor results have already forced the Food and Drug Administration to classify these implants as Class III highest-risk devices. Court cases around the country are already underway, and courageous women around the country are standing up for their rights.
A transvaginal mesh lawsuit has ended in a judgement for a Georgia woman.
C.R. Bard, the manufacturer of the Avaulta line of vaginal mesh devices, has been ordered by a jury to pay a Georgia woman $2 million for her serious bladder mesh injuries. The verdict includes $250,000 in compensatory damages and $1.75 million in punitive damages.
The plaintiff’s vaginal mesh injuries reportedly included perforation to her internal organs, vaginal scarring, pelvic pain and pain during intercourse. According to court documents, the plaintiff’s vaginal mesh complications were so debilitating that she suffered significant negative impacts to her quality of life and eventually had to have the mesh removed.
After 12 hours, a jury in the U.S. District Court for the Southern District of West Virginia delivered their verdict in the case. Their verdict in this bellwether case will play a role in the eventual course of action for thousands of transvaginal mesh lawsuits across the country.
This case highlights the dangers when medical devices are not properly vetted before they are allowed into the marketplace and even worse into patients bodies. In the case of transvaginal mesh, there has already been testimony that the maker of the material used to manufacture the mesh warned that it should not be used for permanent implant in humans. Nevertheless, C.R. Bard chose to take that risk and gamble with the health of patients.
The FDA has received over a thousand reports of Bard Avaulta complications associated with surgical mesh since 2005. In October 2008, the FDA issued an alert about complications associated with transvaginal placement of surgical mesh to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).